South Africa
South Africa's efforts to prosecute a major police corruption case have suffered a setback after businessman Vusimuzi "Cat" Matlala withdrew from a plea agreement that would have seen him testify against senior police officials.
The Pretoria Specialised Commercial Crimes Court declared the agreement null and void after Matlala rejected a tougher 12-year prison sentence proposed by the court. Prosecutors had originally negotiated an effective eight-year sentence in exchange for his guilty plea and cooperation.
Matlala faces charges of fraud, corruption and money laundering linked to the alleged irregular award of a 228-million-rand South African Police Service tender to his company, Medicare24. Under the now-collapsed agreement, he had admitted guilt and was expected to become a key state witness against other accused, including senior police officials.
The National Prosecuting Authority says the collapse of the deal means none of the information contained in Matlala's plea agreement or affidavit can now be used in court, forcing investigators to continue building their case independently. Prosecutors maintain they still have sufficient evidence to proceed with the broader corruption trial.
The failed plea bargain is seen as a significant blow to South Africa's anti-corruption campaign, as Matlala's testimony was expected to help expose alleged corruption within the country's police service.
Matlala and his co-accused remain in custody, with the case due to return to court in September, where the businessman is expected to rejoin the main trial after the breakdown of the plea agreement.
00:59
South Africa: Family murder suspect Ndodana Tshuma remanded until September
02:32
An endangered frog living in the middle of South Africa's Cape Town
02:20
Barrydale: South Africa’s small town becoming an artists’ haven
00:32
Former world champion boxer Zolani Tete killed in South Africa
01:09
South Africa: Beauty Queen Chidimma Adetshina fights deportation
00:51
Former Liberian vice president charged in transnational drug probe